Lushang Freda Pharmaceutical Co (SHSE:600223) Other Operating Expense: ¥343 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600223 Lushang Freda Pharmaceutical Co Ltd SHSE:600223
72 GF Score
Price ¥5.74
GF Value ¥6.83
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lushang Freda Pharmaceutical Co Other Operating Expense?

Lushang Freda Pharmaceutical Co SHSE:600223 -1.20% 72 Other Operating Expense is ¥343 Mil as of Jun. 2026. GuruFocus rates SHSE:600223 with a GF Score™ of 72/100 and a GF Value™ of ¥6.83 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Lushang Freda Pharmaceutical Co's Other Operating Expense for the three months ended in Jun. 2026 was ¥157 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥343 Mil.

Lushang Freda Pharmaceutical Co's quarterly Other Operating Expense declined from Dec. 2025 (¥304 Mil) to Mar. 2026 (¥6 Mil) but then increased from Mar. 2026 (¥6 Mil) to Jun. 2026 (¥157 Mil).

Lushang Freda Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2023 (¥285 Mil) to Dec. 2024 (¥261 Mil) but then increased from Dec. 2024 (¥261 Mil) to Dec. 2025 (¥312 Mil).

Lushang Freda Pharmaceutical Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Lushang Freda Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lushang Freda Pharmaceutical Co Other Operating Expense Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 963.27 881.34 284.61 261.02 311.69

Lushang Freda Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 131.19 -123.77 304.02 5.68 157.36
SHSE:600223
72GF Score
Lushang Freda Pharmaceutical Co Ltd SHSE:600223
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lushang Freda Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥343 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of ¥343 Mil mean?
Lushang Freda Pharmaceutical Co (SHSE:600223) has a Other Operating Expense of ¥343 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Lushang Freda Pharmaceutical Co and its competitors.
Is Lushang Freda Pharmaceutical Co's Other Operating Expense too high?
Lushang Freda Pharmaceutical Co's current Other Operating Expense is ¥343 Mil. Overall, Lushang Freda Pharmaceutical Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lushang Freda Pharmaceutical Co's Other Operating Expense compare to competitors?
Lushang Freda Pharmaceutical Co's Other Operating Expense of ¥343 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Real Estate company?
A good Other Operating Expense depends on the Real Estate industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Lushang Freda Pharmaceutical Co and its competitors. Lushang Freda Pharmaceutical Co's current Other Operating Expense is ¥343 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lushang Freda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co (SHSE:600223) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.83, compared to a current price of ¥5.74 — trading 16% below its estimated fair value. The current Other Operating Expense is ¥343 Mil. Lushang Freda Pharmaceutical Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Lushang Freda Pharmaceutical Co (SHSE:600223), the current Other Operating Expense is ¥343 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lushang Freda Pharmaceutical Co (SHSE:600223) Overvalued in 2026?

Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥5.74 is trading 16% below its estimated GF Value™ of ¥6.83. GuruFocus considers Lushang Freda Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600223:

  • Other Operating Expense: ¥343 Mil
  • GF Value™: ¥6.83 vs. price of ¥5.74 (16% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600223 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lushang Freda Pharmaceutical Co Business Description

Address No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
72GF Score

Get the complete analysis for SHSE:600223

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.74
Price
¥6.83
GF Value